Reuters logo
BRIEF-Lundbeck obtains rights to research in Alzheimer's disease
June 6, 2017 / 5:11 AM / 4 months ago

BRIEF-Lundbeck obtains rights to research in Alzheimer's disease

June 6 (Reuters) - H LUNDBECK A/S

* LUNDBECK OBTAINS RIGHTS TO RESEARCH IN ALZHEIMER‘S DISEASE

* SIGNS DEAL WITH BIOTECH COMPANY IMMUNOBRAIN CHECKPOINT, INC. (IBC) FOR RIGHTS TO RESEARCH IN TREATMENT OF ALZHEIMER‘S DISEASE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below